Welcome to the authorial website of Janice M. Mueller. Based in Lexington, Kentucky, Janice is the sole author of two patent law treatises, co-founder of the Chisum Patent Academy, a full-time academic teaching patent and intellectual property courses for 16 years, a former U.S. Justice Department patent litigator, and a law clerk (1990-92) to Judge Giles S. Rich of the U.S. Court of Appeals for the Federal Circuit. Janice’s published writings and commentary focus on the patent law decisions of the Federal Circuit, which holds exclusive appellate jurisdiction for U.S. patent cases and proceedings, and the U.S. Supreme Court.
Mueller on Patent Law is a comprehensive yet accessible two-volume legal treatise for patent practitioners, available as of 2021 in hard copy from Full Court Press or in digital form on the Fastcase legal research database. This well-organized resource provides concise and timely access to U.S. patent law in the twenty-first century, focusing on game-changing Federal Circuit and Supreme Court decisions.
No longer an obscure specialty, patent law protects intellectual assets of tremendous economic value in the global economy. For better or worse, patent practitioners now confront a tsunami of information and advice offered by websites, blogs, specialty journals, and even smartphone apps. Mueller on Patent Law provides a clearly structured filter through which to absorb the content flood. Rather than a historical encyclopedia, this treatise is a carefully curated guide to understanding the current state of patent law and how it has developed during the Federal Circuit’s tenure.
Volume I of Mueller on Patent Law focuses on the requirements for patentability, both pre- and post-America Invents Act of 2011 (AIA), as well as patent prosecution procedures. Volume II covers patent enforcement and validity challenges, including AIA-implemented post-issuance USPTO review. Both volumes emphasize the criticality of patent claim drafting and interpretation.
Volume I of Mueller on Patent Law covers patentability and validity. It offers a clear-cut approach to understanding the multiple, rigorous requirements for obtaining a U.S. patent. Following introductory chapters overviewing the patent system and the central importance of patent claims, Volume I explicates the cornerstone requirement of novelty and what counts as prior art under both pre- and post-AIA regimes. Volume I also tackles the amorphous landscape of patent eligibility, as well as the bedrock requirements that a patentable invention be useful and not only new but nonobvious. Separate chapters unpack the patent application disclosure requirements of enablement, written description, and best mode. Volume I concludes with chapters analyzing inventorship, the prohibition on double patenting, and the nuts and bolts of prosecuting patents in the USPTO.
Volume II of Mueller on Patent Law analyzes how patents are enforced in the United States and their validity challenged. The volume details patent litigation in the federal courts as well as the America Invents Act (AIA)-implemented proceedings for challenging patentability (IPR, PGR, and CBM). Claim interpretation, jurisdiction and procedure including recent sweeping changes to patent venue, direct and indirect liability (including inducing, contributory, and divided infringement), territoriality concerns, literal and doctrine of equivalents (DOE) infringement, prosecution history estoppel and other legal limitations on DOE liability, declaratory judgment actions, Hatch-Waxman Act pharmaceutical litigation, antitrust issues, remedies, and defenses including inequitable conduct, exhaustion, patent misuse, laches, and equitable estoppel all receive thorough and timely treatment. Because patent protection is frequently global, Volume II explores multi-national procurement and enforcement. Reexamination and reissue in the USPTO are detailed, as is the increasingly important subspecialty of design patent law.
Patent Law delivers a succinct, single-volume explanation of the principal legal doctrines, key judicial authority, governing statutes, and guiding policy considerations in obtaining and enforcing a U.S. patent.
This is the best of the hornbooks on the basics of the patent law. I am both a partner in a law firm who specializes in patent litigation, and an adjunct professor of law. I have been practicing in the field for almost 20 years, and I still find myself going back to this book for easy-to-find, clear and concise answers to patent law questions.
Click here to watch Janice’s March 18, 2021 webinar with Fastcase: “A Conversation with Janice Mueller, Author of Mueller on Patent Law.”
Full Court Press, an imprint of Fastcase, Inc., is the new publisher for the two-volume practitioner treatise, Mueller on Patent Law. Ordering information for hard copy and digital access is available below.
Lastly, Circuit rejects Arthrex‘s argument that PTAB did not have authority to consider s112 written description compliance issue. The ground for IPR was s102 anticipation. It was proper for PTAB to determine s120 priority of challenged claims (req’g WDR analysis) vs. ref’s date.
Director’s (PAS officer’s) discretion under Arthrex (US 2021) includes discretion to delegate review of IPR rehearing requests. Duty to decide them is delegable under Federal Vacancies Reform Act. No FVRA violation here.
Arthrex 5/27 #FedCir holds although Commissioner for Patents is not a Presidentially appointed Senate-confirmed (PAS) officer, he properly issued the final decision here in an acting, stand-in capacity on behalf of the PAS. See Eaton (US 1898). No Appointments Clause violation.
@MichaelKHenry @PatentMemes As @ChisumOnPatents has noted, Justice Breyer (author of Mayo) will no longer be on the Court. Anything is possible.
Kaufman v Microsoft 5/20 #FedCir hands big win to small inventor: sustains $7M jury verdict for K against M's DynamicData product & adds pre-judgment interest. M failed to preserve O2 Micro claim con challenge re "automatically." Jury's lump-sum royalty $ didn't subsume interest.
NB: Inventive entity A+B+C is different from inventive entity A+B. If A+B+C is inventive entity on earlier paper, and only A+B are named inventors on patent, the paper is potential s102(a) art--invention described in printed publication before invention date of applicants (A+B).
Google v IPA 5/19 #FedCir vacates PTAB decision upholding 1990s computer architecture patent. Fundamental testimonial conflict. Named inventors A & B also authored w/ C an earlier paper. Was C mere administrator, or co-inventor of relied-on portions? If latter, paper is 102a ref.
My publisher #Fastcase has launched a spiffy new on-line bookstore: fastcase.com/store/
Newman J dissents: PTAB ruling flawed. #FedCir should accept its jurisdiction and decide the merits: whether PTAB acted reasonably & lawfully in its choice of sanction for AtlantaGas’ handling of real-party-in-interest issue. Majority obscures the efficiency intended by the AIA.
AtlantaGas v BennettReg 5/13 #FedCir 2-1 dismisses appeal from PTAB final decision terminating IPR as a sanction. But Bd's decision not purely about sanctions; evaluation of s315(b) time bar was at "core." So not reviewable per Thryv (2020) & s314(d). Prior mandate not violated.
#FedCir also affirms CDCa's exclusion of certain expert testimony on reasonable royalty damages. Reliability problem: patentee's expert relied on press release but didn't have underlying study. And expert did not adequately consider apportionment, a "conceptually central issue."
SoundView v Hulu 5/11 #FedCir affirms CDCa claim interpn req'g same buffer for concurrent video download/retrieval; S distinguished prior art during prosecution. BUT for comparison step, accused server's "cache" could be buffer. Circuit vacates SJ of no infringement by H; remand.
Reyna J dissents. PTAB relied on more than general skepticism—eg, testimony that due to risks in telesurgery, artisan wouldn’t be motivated to complicate existing robotic system. Majority’s rule too rigid when considering prior art in inherently dangerous field; in tension w KSR.
Auris v Intuitive 4/29 #FedCir 2-1 vacates PTAB determination that Int’s claims wd not hv bn obvious. PTAB erred in relying mainly on general skepticism of using robots in surgery to find lack of motivation to combine robotic surgical system ref w adjustable instrument stand ref.
Sunoco v USVenture 4/29 #FedCir reverses DCt experimental use determination for S. Pre-critical date offer to sell butane blending eqpt for purchase of butane reqt’s was commercial offer per Pfaff prong 1; see Helsinn. Testing at 3d-pty facility was to ensure worked as promised.
Also, whether words appear in the preamble versus the body of a claim does not necessarily determine whether they're limiting (i.e., in establishing un-patentability, whether they must be met by the prior art).
Nichia v DocSecurity 4/26 #FedCir NON-precedential affirms PTAB interpretation that "A display comprising" is the claim's preamble. When did the "comprising" transition phrase become part of the preamble? Isn't the preamble just "[a] display"?
Additionally, the disputed limitation appears to be original claim language. WDR compliance should not be in dispute, in this author's opinion.
Ascion v AshleyFurn 4/22 NON-precedential #FedCir correctly vacates SJ invalid/lack written description. Art worker could understand stacking modular legs for mattress have "substantially horizontal bottom" even though not shown or explicitly described; they need to fit together.
Minimum contacts: Z (SC corp) sent multiple letters to A in Cal. and travelled there 2x for licensing discussions. Z "amplified" its infringement allegations after A stated it did not need a license. Z sued A for infringement in GA in 2020 (dismissed); A's DJ in Cal. foreseeable.
©2022 Janice Mueller - All Rights Reserved
(855) 324-4786 | janice@chisum.com
Website design by Bluegrass Internet Services